Vitamin D and the anti-viral state.
Beard. Jeremy A JA; Bearden. Allison A; Striker. Rob R
Key Findings
- Low vitamin D is linked to higher risk of flu, respiratory infections, and is common in HIV patients
- Vitamin D can increase production of antimicrobial peptides like LL‑37 and beta‑defensin 2
- Cell studies suggest vitamin D has direct antiviral effects, especially against enveloped viruses, though the exact mechanism is still unclear
Practical Outcomes
- Keeping vitamin D levels in the optimal range (e.g., 30‑50 ng/mL blood 25‑OH D) through safe supplementation may help boost LL‑37 and overall antiviral defenses. This isn’t a cure, but a low‑risk strategy to support immunity alongside other health measures.
Summary
Vitamin D isn’t just for bones – it helps the immune system and can boost the body’s natural antiviral peptide LL‑37, which may lower the chance of getting flu or other viral infections.
Abstract
Vitamin D has long been recognized as essential to the skeletal system. Newer evidence suggests that it also plays a major role regulating the immune system, perhaps including immune responses to viral infection. Interventional and observational epidemiological studies provide evidence that vitamin D deficiency may confer increased risk of influenza and respiratory tract infection. Vitamin D deficiency is also prevalent among patients with HIV infection. Cell culture experiments support the thesis that vitamin D has direct anti-viral effects particularly against enveloped viruses. Though vitamin D's anti-viral mechanism has not been fully established, it may be linked to vitamin D's ability to up-regulate the anti-microbial peptides LL-37 and human beta defensin 2. Additional studies are necessary to fully elucidate the efficacy and mechanism of vitamin D as an anti-viral agent.
Study Information
pubmed
2011
2011-01-15T00:00:00.000Z
10.1016/j.jcv.2010.12.006
398
111